Big Move For Neurotrope, Inc.
Wed, Dec 04, 2019 at 05:30 PM
Neurotrope, Inc. (NTRP:NASDAQ) rocketted at $1.06, representing a gain of 21.3%. On Tue 03 Dec 19, NTRP:NASDAQ hit a New 2-Week Intraday High of $0.92. From Tue 12 Nov 19, the stock recorded 57.14% Up Days and 60.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Neurotrope, Inc. (NTRP:NASDAQ)
Neurotrope Inc is biopharmaceutical company with product candidates in pre-clinical and clinical development. It is engaged in developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease.
Top 10 Gainers:
- Protagonist Therapeutics, Inc. (PTGX:NASDAQ), 72.92%
- iBio, Inc. (IBIO:NYSEMKT), 51.06%
- Kodiak Sciences Inc. (KOD:NASDAQ), 49.21%
- Allakos Inc. (ALLK:NASDAQ), 43.56%
- Jason Industries, Inc. (JASN:NASDAQ), 41.44%
- Anavex Life Sciences Corp. (AVXL:NASDAQ), 28.39%
- Comstock Mining Inc. (LODE:NYSEMKT), 27.71%
- Obsidian Energy Ltd. (OBE:NYSE), 22.55%
- Applied Therapeutics, Inc. (APLT:NASDAQ), 21.7%
- Neurotrope, Inc. (NTRP:NASDAQ), 21.3%